On March 7, 2025, Vertex Pharmaceuticals announced that its cystic fibrosis treatment, ALYFTREK®, had received regulatory approval from the UK's MHRA, a significant milestone in expanding its ...

Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday ... markets and writes the Need to Know column. She has worked in London and Los Angeles for MarketWatch previously.